Velarion Records
Free. Unsubscribe any time.

FENNEC PHARMACEUTICALS INC. (FENC)

FENNEC PHARMACEUTICALS INC. filed 27 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 28 transactions and 306,193 shares. None carries the SEC's AFF10B5ONE flag; all 27 name a plan in a footnote. 2 results prints are on file in the same window.

What stands out

Trades in FENNEC PHARMACEUTICALS INC. 28

Adoption dates in FENNEC PHARMACEUTICALS INC. 5

Results prints in FENNEC PHARMACEUTICALS INC. 2

Trades before a print in FENNEC PHARMACEUTICALS INC. 1

Interval to FENNEC PHARMACEUTICALS INC.’s next reported results date

How the interval and sources are counted →

Adoption dates FENNEC PHARMACEUTICALS INC. states

Filing text: “10b5-1 plan adopted on May 19, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.